" /> Puquitinib Mesylate - CISMeF





Preferred Label : Puquitinib Mesylate;

NCIt definition : The mesylate salt of puquitinib, an orally available selective inhibitor of the delta form of phosphatidylinositol 3-kinase (PI3-kinase subunit delta; PI3K-delta; PI3Kdelta), with potential antineoplastic activity. Upon oral administration, puquitinib selectively binds to the ATP-binding pocket of PI3K-delta and prevents the activation of the PI3K/AKT signaling pathway. This decreases proliferation of and induces cell death in PI3K-delta over-expressing tumor cells. PI3K-delta also plays a key role in the B-cell receptor (BCR) signaling pathway and the proliferation of certain hematologic cancer cells. The targeted inhibition of PI3K-delta is designed to preserve PI3K signaling in normal, non-neoplastic cells, thereby minimizing serious side effects.;

UNII : Z4NA6BNF2L;

InChIKey : XWHARLVGMNPKNZ-UHFFFAOYSA-N;

CAS number : 1018818-41-1; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1018818-41-1 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : XC-302 Anhydrous;

NCI Metathesaurus CUI : CL971077;

Details


You can consult :


Nous contacter.
12/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.